Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Mixed neuroendocrine-non-neuroendocrine carcinoma of gallbladder: case report

A. Skalický, L. Vištejnová, M. Dubová, T. Malkus, T. Skalický, O. Troup,

. 2019 ; 17 (1) : 55. [pub] 20190322

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19027695

Grantová podpora
1170816 Grantová Agentura, Univerzita Karlova

BACKGROUND: Mixed neuroendocrine-non-neuroendocrine tumors (MINEN) of the gallbladder are extremely rare; indeed, the English expert literature reports a mere handful of case reports and case series on this topic. According to the WHO classification of 2010, MINEN are considered to be tumors consisting of two major components, neuroendocrine and non-neuroendocrine, each of which hosts at least 30% of the total cellular population. To date, the etiology and pathogenesis of MINEN have not been precisely determined and the non-specific symptoms generally result in late diagnosis (mainly in the terminal stages of the condition) and contribute to the generally poor prognosis. As far as the management of the disease is concerned, radical surgery plays a crucial role; however, the significance of surgical debulking and biological therapy applying somatostatin analogues has not yet been determined. CASE PRESENTATION: A 56-year-old female was referred to our department for a rapidly progressing tumor in the subhepatic area along with the infiltration of S5 and S6 liver segments. With regard to preoperative findings, the tumor appeared as operable, although, during the surgery, an extensive involvement of the hepatoduodenal ligament by the tumor through the lymph nodes was revealed. Due to acute perioperative bleeding from the necrotic tumor, we decided to perform modified resection. Histologically, the tumor was confirmed as MINEN of gallbladder, where the neuroendocrine component was dominant over the non-neuroendocrine component. Six weeks after the discharge, the patient underwent a follow-up CT revealing large recurrence of the disease. Thereafter, the patient was started on systemic therapy with etoposide and carboplatin in combination with somatostatin analogues. Thirteen months after the surgery, the patient is in good clinical condition, and while a recently performed PET/MRI scan revealed a hepatic lesion and hilar lymphadenopathy in full regression, there was a spread of small peritoneal and pleural metastases. The patient remains in the follow-up care. CONCLUSIONS: The occurrence of mixed neuroendocrine-non-neuroendocrine neoplasms is extremely rare. Radical surgery remains the only potentially effective approach to the cure of this disease. The role of biological therapy and debulking in the management of the disease has not yet been precisely defined. In our experience, both of these methods have the potential to positively influence overall survival rates and the postoperational quality of life of patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027695
003      
CZ-PrNML
005      
20250121100851.0
007      
ta
008      
190813s2019 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12957-019-1598-4 $2 doi
035    __
$a (PubMed)30902091
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Skalický, Adam $u Department of Surgery and Biomedical Center, Faculty of Medicine and University Hospital in Pilsen, Charles University in Prague, 304 60, Pilsen, Czech Republic. skalickya@fnplzen.cz.
245    10
$a Mixed neuroendocrine-non-neuroendocrine carcinoma of gallbladder: case report / $c A. Skalický, L. Vištejnová, M. Dubová, T. Malkus, T. Skalický, O. Troup,
520    9_
$a BACKGROUND: Mixed neuroendocrine-non-neuroendocrine tumors (MINEN) of the gallbladder are extremely rare; indeed, the English expert literature reports a mere handful of case reports and case series on this topic. According to the WHO classification of 2010, MINEN are considered to be tumors consisting of two major components, neuroendocrine and non-neuroendocrine, each of which hosts at least 30% of the total cellular population. To date, the etiology and pathogenesis of MINEN have not been precisely determined and the non-specific symptoms generally result in late diagnosis (mainly in the terminal stages of the condition) and contribute to the generally poor prognosis. As far as the management of the disease is concerned, radical surgery plays a crucial role; however, the significance of surgical debulking and biological therapy applying somatostatin analogues has not yet been determined. CASE PRESENTATION: A 56-year-old female was referred to our department for a rapidly progressing tumor in the subhepatic area along with the infiltration of S5 and S6 liver segments. With regard to preoperative findings, the tumor appeared as operable, although, during the surgery, an extensive involvement of the hepatoduodenal ligament by the tumor through the lymph nodes was revealed. Due to acute perioperative bleeding from the necrotic tumor, we decided to perform modified resection. Histologically, the tumor was confirmed as MINEN of gallbladder, where the neuroendocrine component was dominant over the non-neuroendocrine component. Six weeks after the discharge, the patient underwent a follow-up CT revealing large recurrence of the disease. Thereafter, the patient was started on systemic therapy with etoposide and carboplatin in combination with somatostatin analogues. Thirteen months after the surgery, the patient is in good clinical condition, and while a recently performed PET/MRI scan revealed a hepatic lesion and hilar lymphadenopathy in full regression, there was a spread of small peritoneal and pleural metastases. The patient remains in the follow-up care. CONCLUSIONS: The occurrence of mixed neuroendocrine-non-neuroendocrine neoplasms is extremely rare. Radical surgery remains the only potentially effective approach to the cure of this disease. The role of biological therapy and debulking in the management of the disease has not yet been precisely defined. In our experience, both of these methods have the potential to positively influence overall survival rates and the postoperational quality of life of patients.
650    _2
$a protokoly protinádorové kombinované chemoterapie $x terapeutické užití $7 D000971
650    _2
$a neuroendokrinní karcinom $x diagnóza $x patologie $x terapie $7 D018278
650    _2
$a cholecystektomie $x metody $7 D002763
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a žlučník $x diagnostické zobrazování $x patologie $x chirurgie $7 D005704
650    _2
$a nádory žlučníku $x diagnóza $x patologie $x terapie $7 D005706
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a maligní smíšený nádor $x diagnóza $x patologie $x terapie $7 D018198
650    _2
$a lokální recidiva nádoru $x diagnostické zobrazování $x terapie $7 D009364
650    _2
$a počítačová rentgenová tomografie $7 D014057
650    _2
$a výsledek terapie $7 D016896
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vištejnová, Lucie $u Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 304 60, Pilsen, Czech Republic.
700    1_
$a Dubová, Magdaléna $u Šikl's Department of Pathology, Faculty of Medicine and University Hospital in Pilsen, Charles University, 305 99, Pilsen, Czech Republic.
700    1_
$a Malkus, Tomáš $u Department of Imaging Methods, University Hospital in Pilsen, 304 60, Pilsen, Czech Republic.
700    1_
$a Skalický, Tomáš $u Department of Surgery and Biomedical Center, Faculty of Medicine and University Hospital in Pilsen, Charles University in Prague, 304 60, Pilsen, Czech Republic.
700    1_
$a Troup, Ondřej $u Faculty of Medicine in Pilsen, Charles University, 301 00, Pilsen, Czech Republic. $7 xx0327816
773    0_
$w MED00008253 $t World journal of surgical oncology $x 1477-7819 $g Roč. 17, č. 1 (2019), s. 55
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30902091 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20250121100848 $b ABA008
999    __
$a ok $b bmc $g 1432844 $s 1066155
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 17 $c 1 $d 55 $e 20190322 $i 1477-7819 $m World journal of surgical oncology $n World J Surg Oncol $x MED00008253
GRA    __
$a 1170816 $p Grantová Agentura, Univerzita Karlova
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...